This session is dedicated to a discussion of current regulatory and legislative issues affecting health outcomes research. Speakers from the U.S. Food and Drug Administration, the pharmaceutical industry, patient advocacy, and policy think tanks will address current issues surrounding health outcomes research, including patient-centered research and development, promotion of health economic claims, and role of regulatory oversight in a dynamic health care environment.